Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v7-EN
Language French English
Date Updated 2019-05-07 2019-05-07
Drug Identification Number 02314185 02314185
Brand name SANDOZ RABEPRAZOLE SANDOZ RABEPRAZOLE
Common or Proper name RABEPRAZOLE RABEPRAZOLE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients RABEPRAZOLE SODIUM RABEPRAZOLE SODIUM
Strength(s) 20MG 20MG
Dosage form(s) TABLET (ENTERIC-COATED) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 3X10 / Plq 3X10 / Plq
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-02-04 2019-02-04
Estimated end date 2019-05-06 2019-05-06
Actual end date 2019-04-29 2019-04-29
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Available in format of 100Tab and 500Tab Available in format of 100Tab and 500Tab
Health Canada comments